Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II/III Study of YM150 - A Placebo-controlled, Double-blind, Group Comparison Study in Patients Undergoing Elective Total Hip Replacement Surgery

NCT00913120 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00913120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00913120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II/III Study of YM150 - A Placebo-controlled, Double-blind, Group Comparison Study in Patients Undergoing Elective Total Hip Replacement Surgery
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2/3
Overall status
Completed
Start date
May 31, 2009
Completion date
March 31, 2010
Enrollment
610 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism